ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jan 8, 2017
Looking Closely at Zimmer Biomet
Image Source: Zimmer Biomet. Medical technology companies have taken their share of lumps as of late, but the long-term may be too bright for investors to ignore Zimmer Biomet's shares.
Jan 6, 2017
Department Stores Limp Across Finish Line In 2016
2016 was an abysmal year for major department and general merchandise stores, and the holiday season offered little relief. 2017 may very well not be any different for the group.
Jan 6, 2017
CVS Health In The Bargain Bin? We Think So
Image Source: Mike Mozart. We are adding CVS Health to the newsletter portfolios.
Jan 4, 2017
General Motors Gains US Market Share in December; Shares Racing Higher
Image Source: Tina Rossini. Newsletter portfolios holding General Motors announced impressive sales results in the month of December. Shares are surging as a result.
Jan 1, 2017
Dividend Increases/Decreases for the Week Ending December 30
Let's take a look at companies raising/lowering their dividends this week.
Jan 1, 2017
Dividend Growth Newsletter: Evaluating Our 2016 Dividend Growth Picks
What say us of our dividend growth stock-selection skills?
Dec 29, 2016
5 Shocking Stock Market Predictions for 2017
Image Source: Claudia Dea. Valuentum: 2017 Is the Year of Evangeline Adams.
Dec 24, 2016
Dividend Increases/Decreases for the Week Ending December 23
Let's take a look at companies raising/lowering their dividends this week.
Dec 23, 2016
Words Cannot Express How I Feel
Image: Another day at the office. Words cannot express how I feel.
Dec 22, 2016
More Consolidation in Industrial Gas Industry: Praxair and Linde
Industrial gas giants Praxair and Linde have agreed to a merger of equals after years of negotiations, but the deal is far from a certainty.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.